Series B - Ophelia

Series B - Ophelia

Investment Firm

Overview

Ophelia offers medication and support for quitting opioids.

Announced Date

Dec 14, 2021

Funding Type

Series B

Highlights

Location

New York, New York, United States, North America

Social

Investor Lead

Tiger Global Management

Tiger Global Management

Tiger Global Management is a early_stage_venture and late_stage_venture and post_ipo and private_equity and secondary_market and seed firm.

Participant Investors

8

Investor Name
Participant InvestorElliot Cohen
Participant InvestorRefactor
Participant InvestorInterplay
Participant InvestorMenlo Ventures
Participant InvestorGeneral Catalyst

Round Details and Background

Ophelia raised $50000000 on 2021-12-14 in Series B

Ophelia offers medication and support for quitting opioids.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 12, 2020
Seed Round - Ophelia
3-2.7M
Apr 22, 2021
Series A - Ophelia
11-15.0M
Dec 14, 2021
Series B - Ophelia
8-50.0M

Recent Activity

There is no recent news or activity for this profile.